Bcr/Abl activates transcription of the Bcl-X gene through STAT5

Blood

Volumn 96, Issue 6, 2000, Pages 2269-2276

  Gesbert, F ^a   Griffin, J D ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; INTERLEUKIN 3; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN TYROSINE KINASE; STAT5 PROTEIN;

ANIMAL CELL; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENETIC TRANSCRIPTION; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REPORTER GENE;

EID: 0034665780     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.6.2269     Document Type: Article

References (37)

1. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gone
2. Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2
3. BCR/ABL confers growth factor independence upon a murine myeloid cell line
4. Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells
5. Transformation of hematopoietic cells by BCR/ABL requires activation of a Pl-3k/Akt-dependent pathway
6. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation
7. Dominant negative MYC blocks transformation by ABL oncogenes
8. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl
9. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia
10. Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5
11. STATs: Signal transducers and activators of transcription
12. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype
13. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation
14. Mouse oncostatin M: An immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway
15. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: A direct role for Stat5 in BcI-X(L)induction
16. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
17. Anti-apoptotic activity of Stat5 required during terminal stages of myeloid differentiation
18. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation
19. Functional interaction of STAT5 and Nuclear receptor corepressor, SMRT: Implications in negative regulation of STAT5-dependent transcription
20. STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells
21. Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gone
22. Secondary mutation maintains the transformed state in BaF3 cells with inducible BCR/ABL expression
23. Erythropoietin can induce the expression of bcl-x(L) through Slat5 in erythropoietin-dependent progenitor cell lines
24. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line
25. A minute chromosome in human chronic granulocytic leukemia
26. Bcr-Abl oncoproteins bind directly to activators of the ras signalling pathway
27. inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
28. Adhesive defects in chronic myeloid leukemia
29. Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling
30. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl
31. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients
32. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis
33. Use of a temperature sensitive mutant to define the biological effects of the p210bcr/abl tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line
34. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins
35. BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: A mechanism of resistance to multiple anticancer agents
36. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL STAT5 involvement in the differentiation response of primary chicken myeloid progenitor cells to chicken myelomonocytic growth factor
37. The survival function of the bcr-Abl oncogene is mediated by bad-dependent and -independent pathways: Roles for phosphatidylinositol 3- kinase and Raf